Dutch Bros Inc.

Dutch Bros, a small U.S. coffee chain, is a growth stock that "could supercharge your returns over the next five years and beyond," <a href="https://www.fool.com/investing/2026/02/26/growth-stock-supercharge-invest-return-5-years/">argues</a>&nbsp;Motley Fool contributing analyst Neil Patel. The company’s stock is trading about 45% below its peak even as its fundamentals remain strong, he says, creating an attractive entry point for investors.

Motley Fool analyst likes growing U.S. coffee chain Dutch Bros on dip

VolitionRx Limited

Shares of VolitionRx, a micro-cap developer of blood tests for cancer and sepsis, <a href="https://finance.yahoo.com/quote/VNRX/">jumped</a>&nbsp;nearly 26% on Tuesday after the company <a href="https://ir.volition.com/news-events/press-releases/detail/874/volitionrx-highlights-commercial-momentum-and-multi-pillar-execution">reported</a>&nbsp;progress in several research programs and said a newly developed cancer-detection method has attracted interest from potential partners. The company also highlighted breakthrough research on detecting lymphoma in cats. Wall Street analysts <a href="https://www.marketwatch.com/investing/stock/vnrx/analystestimates?mod=mw_quote_tab">say</a>&nbsp;the stock could have nearly 790% upside.

Cancer blood test maker VolitionRX soars 25% in a day on reported commercial progress

NVIDIA Corporation

Salesforce, Inc.

IonQ, Inc.

Nutanix, Inc.

Synopsys, Inc.

Advanced Micro Devices, Inc.

The Trade Desk, Inc.

Warner Bros. Discovery, Inc.

Paramount Skydance Corporation

Netflix, Inc.

Thomson Reuters Corporation

United Therapeutics Corporation

Circle Internet Group

Clear Secure, Inc.

Jazz Pharmaceuticals plc

Daily review and forecast of events on the U.S. stock market from Mikhail Denislamov, Deputy Director of Freedom Capital Markets Research.

New York morning: markets assess Nvidia report and look for new drivers

What are analysts saying about the results of one of the AI race leaders and what to expect from it next?

'The extraordinary seems ordinary': why Wall Street has embraced Nvidia's report without enthusiasm

Paramount's quarterly loss jumped 2.5 times amid falling revenue from TV networks

Revenue at Paramount's only profitable business has plummeted. Will its purchase by Warner save it?

Deckers Outdoor Corporation

Henry Schein, Inc.

HP Inc.

Victoria's Secret & Co.

David Einhorn, the founder of hedge fund Greenlight Capital, seriously <a href="https://www.sec.gov/Archives/edgar/data/1489933/0001172661-26-001122-index.html">revamped</a> his portfolio last quarter, almost completely getting rid of HP securities in favor of companies from the industrial sector and media business. The most notable deal was the purchase of shares of Warner Bros. Discovery. Over the past quarter, the value of the fund's public portfolio <a href="https://seekingalpha.com/article/4853256-tracking-david-einhorns-greenlight-capital-portfolio-q3-2025-update">grew by </a>12% to $2.85 billion.

Movies, running and AI skepticism: what the investor who predicted Lehman's collapse changed in his portfolio

Salesforce will target $50 billion to buy back its shares from the market, deeming its current price low

Salesforce earnings beat expectations, but the stock fell 5%. What spooked investors?

Amazon.com, Inc.

Nvidia reported record revenue of $68.1 billion last quarter thanks to the data center boom and forecasts up to $79.6 billion for the current period. The company finally received a U.S. license for limited shipments of its H200 artificial intelligence chips to China. And Amazon is discussing a major investment in developer ChatGPT. These and other topics - in the review of key events for the morning of February 26.

Top story for the morning: Nvidia beats forecasts, Amazon prepares up to $50 billion for OpenAI

Eli Lilly and Company

Novo Nordisk A/S

JPMorgan, Deutsche Bank and RBC Capital believe that pharmaceutical company Eli Lilly will be the main beneficiary of the rapidly growing market of GLP-1 weight loss drugs. Analysts point to the higher efficacy of its therapy compared to competitors, development of direct sales and potential expansion of insurance coverage.

Three investment banks named Eli Lilly as the leader in the weight loss drug race

Oracle Corporation

Investment bank Oppenheimer advised to seize the opportunity and buy shares of software developer and owner of cloud storage Oracle. The analyst believes that the recent sharp fall in the company's quotations has formed an attractive ratio of risk and potential returns for investors.

Oppenheimer recommended buying Oracle stock on the downturn. Why he expects them to grow by 25%

Citigroup Inc.

Visa Inc.

Microsoft Corporation

Bank of America Corporation

Mastercard Incorporated

Morgan Stanley strategists believe the excessive sell-off in stocks amid concerns around artificial intelligence is creating opportunities for "selective investors." The bank recommends looking for the next "AI market leaders" - fast-growing companies that could benefit from lower valuations and accelerating adoption of AI technology.

Morgan Stanley calls AI panic a chance for selective investors. What's his advice?

The world's most valuable company has published a report at a critical time for the US stock market as investors get nervous about the impact of AI 

Donald Trump